Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lululemon Athletica Inc (LULU) vs Rivian Automotive, Inc. (RIVN) Price & Performance

Lululemon Athletica IncTrade
Rivian Automotive, Inc.Trade

Price performance (Past 24H)

Key statistics

Lululemon Athletica Inc vs Rivian Automotive, Inc. — how do they compare? Lululemon Athletica Inc trades at $94.4 (market cap $10.27B), while Rivian Automotive, Inc. trades at $13.95 (market cap $20.75B). The key difference: Rivian Automotive, Inc. is far larger — about 2× Lululemon Athletica Inc's market cap, and Rivian Automotive, Inc. is trading nearer its 52-week high, Lululemon Athletica Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Lululemon Athletica Inc for 105 Days and Rivian Automotive, Inc. for 61 Days on average.

LULURIVN
Market Cap
$10.27B$20.75B
Volume
4,392,32426,144,654
Sector
Consumer CyclicalConsumer Cyclical
52-Week High
$215.88$22.45
52-Week Low
$91.88$12.50
Typical Hold Time
105 Days61 Days
Enterprise Value
$11.02B$20.79B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lululemon Athletica Inc

Lululemon stock trades at $94.5, down 54% year-to-date and near its 52-week low, reflecting a bearish technical trend. Despite strong profitability with a 12.78% net income margin and a low P/E of 7.63, the stock faces headwinds from recent revenue declines and multiple securities fraud investigations. Earnings have beaten estimates in recent quarters, but negative sentiment and governance concerns weigh on investor confidence.

The outlook remains cautious; the stock's deep discount to historical valuations presents a potential opportunity, but risks from legal probes, competitive pressures, and weak growth visibility suggest limited near-term upside. Analyst consensus is mixed with a $97.67 price target, indicating modest potential from current levels amid high uncertainty.

Rivian Automotive, Inc.

Rivian Automotive (RIVN) trades at $13.96, down 2.65% amid bearish technical signals despite strong Q3 2026 delivery results. The company reported record production of 19,751 vehicles and deliveries of 19,248, beating estimates but maintaining unchanged guidance. Fundamentally, RIVN shows improving revenue growth ($5.39B in 2025) but continues significant losses (-$3.65B net income) with negative margins. Analyst consensus remains cautiously optimistic with a $16.89 price target, though technical indicators show 18 sell signals versus 2 buy signals.

Rivian's investment case balances strong delivery growth and R2 SUV ramp-up against persistent cash burn and competitive EV market pressures. The stock offers upside to analyst targets but faces execution risks in achieving profitability. Key catalysts include R2 production scaling and autonomy technology rollout, while main risks involve cash flow sustainability and intense industry competition.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LULU
46% Buy54% Sell
Avg holding period · 105 Days
RIVN

No sentiment data available yet.

Top news

Latest headlines on both assets

About Lululemon Athletica Inc

Lululemon Athletica Inc. designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 600 company-owned stores in 18 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.

Read more on LULU →

About Rivian Automotive, Inc.

Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.

Read more on RIVN →